Content Type: White Paper

As the demand for peptide-based therapeutics continues to grow, the need for innovative, cost-efficient, and environmentally friendly manufacturing…

Oligonucleotide-based therapeutics are transforming modern medicine, offering targeted solutions for genetic disorders, cancer, cardiovascular disease, and CNS conditions.…

Oligonucleotides are emerging as a powerful new class of therapeutics that show promise as groundbreaking therapies for previously…

In today’s unpredictable world, ensuring a resilient pharmaceutical supply chain is more critical than ever. Bachem’s white paper,…

Oligonucleotide-based active pharmaceutical ingredients (APIs) have emerged as a powerful approach to treating diseases. With hundreds of them…

In a changing world, where global warming and limited resources are a priority, our vision and the way…

Executive Summary Microspheres-and-Nanoparticles-for-Peptide-Delivery Proteins and peptides fulfill an irreplaceable role as medicines due to their high affinity, specificity,…

The innovative PEC platform enables the efficient putification even of complex peptides Overview Innovation is a central pillar…